FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030330160> ?p ?o ?g. }

• W2030330160 endingPage "1212" @default.
• W2030330160 startingPage "1208" @default.
• W2030330160 abstract "ObjectiveThis study was conducted to determine the outcomes and predictive factors for success during percutaneous endovascular aneurysm repair (PEVAR) using vascular closure devices (VCDs).MethodsThe clinical data of patients who underwent PEVAR between 2005 and 2012 were retrospectively reviewed. Patient demographics, body mass index, sheath size, device types, diameter of femoral arteries, and extent and location of femoral artery calcification were recorded. Included were all consecutive patients treated by PEVAR with sheath sizes ranging from 12F to 24F. End points were technical success, conversion to open femoral artery repair, and complications.ResultsDuring this period, 752 patients were treated by EVAR. Of these, 391 femoral arteries in 222 patients (29.5%; 197 men, 25 women), with a mean age of 74.8 years (range, 51-93.7 years), underwent PEVAR (169 bilateral and 53 unilateral percutaneous access). Patients with >50% anterior femoral artery calcifications or those with previous femoral artery reconstructions were not offered PEVAR. Technical success of PEVAR was 96.4% (377 of 391), with an average of two VCDs used per groin. Fourteen intraoperative failures were managed with open femoral conversion using primary repair (five) or patch angioplasty (nine). In nine patients, the procedure was converted from local to general anesthesia. Four patients required a perioperative blood transfusion. There were no significant differences in body mass index (P = .26), femoral artery size preprocedure (P = .33) or postprocedure (P = .37), sheath size (≥20F vs ≤18F), or type of VCD used between the success and failure groups. Pairwise comparisons revealed increased failure rate (P < .001) between patients with <50% anterior wall calcification vs none, <50% anterior wall calcification vs <50% posterior wall calcification, and none vs >50% posterior calcification. There was no significant difference (P = .53) between patients with <50% posterior wall calcification and those with no calcification. The 30-day mortality of the entire group was 0.9% (2 of 222 patients). No deaths occurred after conversion to open femoral closure. At a mean follow-up of 30 months (range, 1-85.2 months), there were no long-term groin complications or iliac limb occlusions.ConclusionsPEVAR using VCDs can be performed with high technical success in patients with <50% anterior wall calcification, regardless of the size of the access sheath or the patient's body mass index. Femoral artery calcification, however, is a major determinant of failure. This study was conducted to determine the outcomes and predictive factors for success during percutaneous endovascular aneurysm repair (PEVAR) using vascular closure devices (VCDs). The clinical data of patients who underwent PEVAR between 2005 and 2012 were retrospectively reviewed. Patient demographics, body mass index, sheath size, device types, diameter of femoral arteries, and extent and location of femoral artery calcification were recorded. Included were all consecutive patients treated by PEVAR with sheath sizes ranging from 12F to 24F. End points were technical success, conversion to open femoral artery repair, and complications. During this period, 752 patients were treated by EVAR. Of these, 391 femoral arteries in 222 patients (29.5%; 197 men, 25 women), with a mean age of 74.8 years (range, 51-93.7 years), underwent PEVAR (169 bilateral and 53 unilateral percutaneous access). Patients with >50% anterior femoral artery calcifications or those with previous femoral artery reconstructions were not offered PEVAR. Technical success of PEVAR was 96.4% (377 of 391), with an average of two VCDs used per groin. Fourteen intraoperative failures were managed with open femoral conversion using primary repair (five) or patch angioplasty (nine). In nine patients, the procedure was converted from local to general anesthesia. Four patients required a perioperative blood transfusion. There were no significant differences in body mass index (P = .26), femoral artery size preprocedure (P = .33) or postprocedure (P = .37), sheath size (≥20F vs ≤18F), or type of VCD used between the success and failure groups. Pairwise comparisons revealed increased failure rate (P < .001) between patients with <50% anterior wall calcification vs none, <50% anterior wall calcification vs <50% posterior wall calcification, and none vs >50% posterior calcification. There was no significant difference (P = .53) between patients with <50% posterior wall calcification and those with no calcification. The 30-day mortality of the entire group was 0.9% (2 of 222 patients). No deaths occurred after conversion to open femoral closure. At a mean follow-up of 30 months (range, 1-85.2 months), there were no long-term groin complications or iliac limb occlusions. PEVAR using VCDs can be performed with high technical success in patients with <50% anterior wall calcification, regardless of the size of the access sheath or the patient's body mass index. Femoral artery calcification, however, is a major determinant of failure." @default.
• W2030330160 created "2016-06-24" @default.
• W2030330160 creator A5005427596 @default.
• W2030330160 creator A5038895192 @default.
• W2030330160 creator A5043875322 @default.
• W2030330160 creator A5051427859 @default.
• W2030330160 creator A5053378731 @default.
• W2030330160 creator A5055044637 @default.
• W2030330160 creator A5089382393 @default.
• W2030330160 date "2013-11-01" @default.
• W2030330160 modified "2023-10-09" @default.
• W2030330160 title "Femoral artery calcification as a determinant of success for percutaneous access for endovascular abdominal aortic aneurysm repair" @default.
• W2030330160 cites W1593776909 @default.
• W2030330160 cites W1970144614 @default.
• W2030330160 cites W1989760968 @default.
• W2030330160 cites W1999299049 @default.
• W2030330160 cites W2004772674 @default.
• W2030330160 cites W2054435202 @default.
• W2030330160 cites W2060935153 @default.
• W2030330160 cites W2118396626 @default.
• W2030330160 cites W2133735040 @default.
• W2030330160 cites W2159513177 @default.
• W2030330160 cites W2164718491 @default.
• W2030330160 doi "https://doi.org/10.1016/j.jvs.2013.05.028" @default.
• W2030330160 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23830310" @default.
• W2030330160 hasPublicationYear "2013" @default.
• W2030330160 type Work @default.
• W2030330160 sameAs 2030330160 @default.
• W2030330160 citedByCount "69" @default.
• W2030330160 countsByYear W20303301602014 @default.
• W2030330160 countsByYear W20303301602015 @default.
• W2030330160 countsByYear W20303301602016 @default.
• W2030330160 countsByYear W20303301602017 @default.
• W2030330160 countsByYear W20303301602018 @default.
• W2030330160 countsByYear W20303301602019 @default.
• W2030330160 countsByYear W20303301602020 @default.
• W2030330160 countsByYear W20303301602021 @default.
• W2030330160 countsByYear W20303301602022 @default.
• W2030330160 countsByYear W20303301602023 @default.
• W2030330160 crossrefType "journal-article" @default.
• W2030330160 hasAuthorship W2030330160A5005427596 @default.
• W2030330160 hasAuthorship W2030330160A5038895192 @default.
• W2030330160 hasAuthorship W2030330160A5043875322 @default.
• W2030330160 hasAuthorship W2030330160A5051427859 @default.
• W2030330160 hasAuthorship W2030330160A5053378731 @default.
• W2030330160 hasAuthorship W2030330160A5055044637 @default.
• W2030330160 hasAuthorship W2030330160A5089382393 @default.
• W2030330160 hasBestOaLocation W20303301601 @default.
• W2030330160 hasConcept C126838900 @default.
• W2030330160 hasConcept C141071460 @default.
• W2030330160 hasConcept C2779495589 @default.
• W2030330160 hasConcept C2779723990 @default.
• W2030330160 hasConcept C2779967601 @default.
• W2030330160 hasConcept C2780813298 @default.
• W2030330160 hasConcept C31174226 @default.
• W2030330160 hasConcept C71924100 @default.
• W2030330160 hasConceptScore W2030330160C126838900 @default.
• W2030330160 hasConceptScore W2030330160C141071460 @default.
• W2030330160 hasConceptScore W2030330160C2779495589 @default.
• W2030330160 hasConceptScore W2030330160C2779723990 @default.
• W2030330160 hasConceptScore W2030330160C2779967601 @default.
• W2030330160 hasConceptScore W2030330160C2780813298 @default.
• W2030330160 hasConceptScore W2030330160C31174226 @default.
• W2030330160 hasConceptScore W2030330160C71924100 @default.
• W2030330160 hasIssue "5" @default.
• W2030330160 hasLocation W20303301601 @default.
• W2030330160 hasLocation W20303301602 @default.
• W2030330160 hasOpenAccess W2030330160 @default.
• W2030330160 hasPrimaryLocation W20303301601 @default.
• W2030330160 hasRelatedWork W1504582425 @default.
• W2030330160 hasRelatedWork W2001477670 @default.
• W2030330160 hasRelatedWork W2044906405 @default.
• W2030330160 hasRelatedWork W2045080269 @default.
• W2030330160 hasRelatedWork W2115543243 @default.
• W2030330160 hasRelatedWork W2166446701 @default.
• W2030330160 hasRelatedWork W2506976682 @default.
• W2030330160 hasRelatedWork W3118370570 @default.
• W2030330160 hasRelatedWork W4379375601 @default.
• W2030330160 hasRelatedWork W2153850051 @default.
• W2030330160 hasVolume "58" @default.
• W2030330160 isParatext "false" @default.
• W2030330160 isRetracted "false" @default.
• W2030330160 magId "2030330160" @default.
• W2030330160 workType "article" @default.